Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge
Ethiopian Medical Journal · 2024
DOI: 10.4314/emj.v62i2.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ethiopian Medical Journal, 2024. Verfasst von Zekewos Demissie und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic Myelogenous Leukemia (CML) is a myeloproliferative neoplasm with a prevalence of 1 to 2 cases per 100,000 adult population. In chronic myelogenous leukemia (CML), central nervous system (CNS) manifestations are reported in the advanced phase of the disease due to leukostasis, thrombosis, bleeding, infection, and CNS infiltration. However, CNS manifestations are uncommon in the chronic phase (CP) of CML, and an alternate diagnosis should be considered for symptomatic patients. We report a ruptured aneurysmal subarachnoid hemorrhage (SAH) as an initial presentation in a previously undetected CML patient.
Zitieren
APA
Demissie, Z., Alemayehu, B., Zemedkun, N., & Tadesse, F. (2024). Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge. Ethiopian Medical Journal. https://doi.org/10.4314/emj.v62i2.7
Vancouver
Demissie Z, Alemayehu B, Zemedkun N, Tadesse F. Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge. Ethiopian Medical Journal. 2024. doi:10.4314/emj.v62i2.7
BibTeX
@article{Demissie2024,
author = {Demissie, Zekewos and Alemayehu, Brook and Zemedkun, Nahom and Tadesse, Fisihatsion},
title = {Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge},
journal = {Ethiopian Medical Journal},
year = {2024},
doi = {10.4314/emj.v62i2.7}
}
EUVIMED